Cancer Screening

NHS North Central London Integrated Care Board has awarded a one-year contract for cancer screening services, starting from 1st April 2025 to 31st March 2026, with no option for extension. The contract, falling under the industry category of medical practice and related services, has a total value of £22,865. This initiative focuses on addressing health inequalities through community engagement, particularly targeting bowel and cervical cancer screenings.

The procurement was conducted under the Provider Selection Regime, regulated by the Health Care Services (Provider Selection Regime) Regulations 2023, and the award was confirmed using a direct award process without prior publication. The service will be delivered in the Boroughs of Haringey and Islington in London, under the functional and geographical jurisdiction of the NHS North Central London Integrated Care Board. This contract presents a valuable opportunity for organisations specialising in health services and community health outreach to expand their operations and impact.

The contract's focus on reducing health inequalities offers significant potential for businesses that excel in innovation, collaboration, and service sustainability, as recognised by the key awarding criteria. Enterprises with expertise in integrating community health support and addressing the needs of minority and underrepresented communities are especially poised to benefit from participating in similar tenders in the future. By fulfilling the requirements outlined, service providers can enhance their reputation and reliability, establishing a strong presence in the public health sector.